Study title:
AN 1977065371 19770101.
TI Cyproheptadine modification of glucagon induced growth hormone release: possible hypothalamic site of glucagon action.
AU AvRuskin-T-W, Lala-V-R, Onur-K, Juan-C-S. IN Dept. Ped., New York Univ. Sch. Med., Brookdale Hosp. Med. Cent., Brooklyn, N.Y., United States.
SO Pediatric Research {PEDIATR-RES}, 1976, Vol/Iss/Pg. 10/4 (no.209). YR 1976.AN 1977065371 19770101.
TI Cyproheptadine modification of glucagon induced growth hormone release: possible hypothalamic site of glucagon action.
AU AvRuskin-T-W, Lala-V-R, Onur-K, Juan-C-S. IN Dept. Ped., New York Univ. Sch. Med., Brookdale Hosp. Med. Cent., Brooklyn, N.Y., United States.
SO Pediatric Research {PEDIATR-RES}, 1976, Vol/Iss/Pg. 10/4 (no.209). YR 1976.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Endocrine System Diseases [C19]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: CYPROHEPTADINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|